EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
0 hedge funds and large institutions have $0 invested in Eucrates Biomedical Acquisition Corp. Unit in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
$0 |
| 2 |
SCM
Sio Capital Management
New York
|
$0 |
| 3 |
CS
Clear Street
New York
|
$0 |
| 4 |
DM
Deerfield Management
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Verition Fund Management
Greenwich,
Connecticut
| – | -$4.12M | -397,603 | Closed |
|
|
SCM
2
Sio Capital Management
New York
| – | -$2.58M | -248,674 | Closed |
|
|
CS
3
Clear Street
New York
| – | -$28.4K | -2,740 | Closed |
|
|
DM
4
Deerfield Management
New York
| – | -$10 | -1 | Closed |
|